ECDC Situation risk assessment    

  WHO EURO Monkeypox webpage    

Surveillance summary

A total of 2746 cases of monkeypox have been identified through IHR/EWRS mechanisms up to 21 June 2022, 14:00, from 29 countries and areas throughout the European region. Case-based data were reported for 1799 cases from 20 countries and areas to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy), up to 21 June 2022, 10:00.

Of the 1799 cases reported in TESSy, 1796 were laboratory confirmed. 21 were confirmed to be of the West African clade. The earliest date of symptom onset was reported as 08 April 2022. The majority of cases were between 31 and 40 years-old (792/1796 - 44.1%) and male (1761/1771 - 99.4%). Among cases with known HIV status, 115/281 - 40.9% were HIV-positive. No cases were reported to have died. So far 5 health care workers were notified as cases in TESSy. None are known to have acquired infection through occupational exposure to date.


INTRODUCTION

PURPOSE AND SCOPE

This report provides an overview of the total number of cases of monkeypox identified by ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms and case-based data through The European Surveillance System (TESSy) up to 21 May 2022.

The first summary table describes the number of cases identified through the different platforms. The following figures and tables describe national case-based data for surveillance of monkeypox reported in TESSy from all the countries and areas of the WHO European Region, including the 27 countries of the European Union (EU) and the additional three countries of the European Economic Area (EEA).

Case Report Form Data are submitted through the case-based record type MPX to The European Surveillance System (TESSy) database hosted at ECDC.

CASE DEFINITION (WHO)

Cases of monkeypox should be reported to TESSy if they meet any of the WHO or ECDC case definitions.

Confirmed case:

  • A case meeting the definition of either a suspected or probable case AND is laboratory confirmed for monkeypox virus by detection of unique sequences of viral DNA either by real-time polymerase chain reaction (PCR) and/or sequencing

Probable case:

  • A person meeting the case definition for a suspected case

AND One or more of the following:

  • has an epidemiological link (face-to-face exposure, including health workers without eye and respiratory protection); direct physical contact with skin or skin lesions, including sexual contact; or contact with contaminated materials such as clothing, bedding or utensils to a probable or confirmed case of monkeypox in the 21 days before symptom onset;
  • reported travel history to a monkeypox endemic country in the 21 days before symptom onset;
  • has had multiple or anonymous sexual partners in the 21 days before symptom onset;
  • has a positive result of an orthopoxvirus serological assay, in the absence of smallpox vaccination or other known exposure to orthopoxviruses;
  • is hospitalized due to the illness

Suspected case:

  • A person of any age presenting in a monkeypox non-endemic country with an unexplained acute rash

AND one or more of the following signs or symptoms, since 15 March 2022:

  • headache, acute onset of fever (>38.5°C), lymphadenopathy (swollen lymph nodes), myalgia (muscle and body aches), back pain, asthenia (profound weakness)

AND for which the following common causes of acute rash do not explain the clinical picture:

  • varicella zoster, herpes zoster, measles, Zika, dengue, chikungunya, herpes simplex, bacterial skin infections, disseminated gonococcus infection, primary or secondary syphilis, chancroid, lymphogranuloma venereum, granuloma inguinale, molluscum contagiosum, allergic reaction (e.g., to plants); and any other locally relevant common causes of papular or vesicular rash.

CASE DEFINITION (ECDC)

Confirmed case:

  • A person with a laboratory-confirmed monkeypox infection (1) monkeypox virus specific PCR assay positive result or (2) orthopoxvirus-specific PCR assay positive result which is then confirmed by nucleotide sequence determination of the detected virus as MPXV) with symptom onset since 1 March 2022.

Probable case:

  1. A person with an unexplained rash* on any part of their body AND one or more other symptom(s) of monkeypox infection** with symptom onset since 1 March 2022

AND one of the following:

  • has a positive laboratory test result on orthopoxviral infection (e.g., orthopoxvirus-specific positive PCR without sequencing, electron microscopy, serology);
  • has an epidemiological link to a confirmed or probable case of monkeypox in the 21 days before symptom onset;
  • reports travel to MPX endemic countries in the 21 days before symptom onset;
  • is a person (of any sexual orientation) who had multiple or anonymous sexual partners in the 21 days before symptom onset;
  • is a man who has sex with men.

OR

  1. A person with an unexplained generalized or localized maculopapular or vesiculopustular rash with centrifugal spread, with lesions showing umbilication or scabbing, lymphadenopathy and one or more other MPX-compatible symptoms**

*Since EU/EEA countries are just starting to identify cases and if testing capacity is sufficient, the above more sensitive case definition can be used. In countries with limited testing capacity for orthopoxviruses, the following description can be added to characterize the rash: ‘unexplained localized or generalized maculopapular or vesiculopustular rash potentially with umbilication or scabbing’.

**Fever (usually higher >38.5°C), headache, back ache, fatigue, lymphadenopathy (localized or generalized).

KEY INDICATORS

IHR SUMMARY

Summary of number of cases of monkeypox identified through IHR/EWRS mechanisms and reported to TESSy, European Region, 2022

EPICURVES

Overall by date of symptom onset

Overall number of cases of monkeypox, per date of symptom onset, European Region, TESSy, 2022

By date of onset and by country or area

Number of cases of monkeypox, per day and per country/area of notification, European Region, TESSy, 2022

By date of onset and by country or area - country/area level

Number of cases of monkeypox, per day and per country/area of notification, European Region, TESSy, 2022

*Day of symptom onset or earliest of day of diagnosis or notification if missing

SUMMARY TABLE

Summary of number of probable and confirmed cases of monkeypox by reporting country/area, European Region, TESSy, 2022

MAP

ECDC Map

WHO-EURO Map

DEMOGRAPHICS

Age and sex distribution of cases of monkeypox, European Region, TESSy, 2022

Information on sex is missing for 28 cases and information on age is missing for 3 cases.

CLINICAL DESCRIPTION

Distribution of symptoms among those reporting at least one type of symptoms (N=660), European Region, TESSy, 2022

*Fever, fatigue, muscle pain, vomiting, diarrhea, chills, sore throat, headache

Detection of asymptomatic cases is dependent on testing guidelines which currently do not recommend testing asymptomatic persons

OUTCOME, HIV STATUS, HCW

Summary of outcome, HIV status, and cases of monkeypox among health care workers, European Region, TESSy, 2022

*Includes cases hospitalized for isolation or treatment (13 cases were hospitalized for isolation purposes,10 required clinical care and 12 were hospitalized for unknown reasons).

SEXUAL ORIENTATION

Summary of reported sexual orientations among cases of monkeypox, European Region, TESSy, 2022

Sexual orientation in TESSy is defined according to the following non-mutually exclusive categories:

  • Heterosexual
  • MSM = MSM/homo or bisexual male
  • Women who have sex with women
  • Bisexual
  • Other
  • Unknown or undetermined

Sexual orientation is not necessarily representative of the gender of the person the case had sex with in the past 21 days nor does it imply sexual contact and sexual transmission.

We summarize here the sexual orientation that male cases identified with. No differences were observed across age groups.

MICROBIOLOGICAL ANALYSES

SPECIMEN TYPES

Summary of specimen types tested positive for monkeypox, European Region, TESSy, 2022